Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin.
about
Non-antiepileptic drugs for trigeminal neuralgiaNon-antiepileptic drugs for trigeminal neuralgiaCurrent status and future directions of botulinum neurotoxins for targeting pain processingBotulinum Toxin Type a as a Therapeutic Agent against Headache and Related DisordersEmerging opportunities for serotypes of botulinum neurotoxinsThe neurology of itchDevelopment of onabotulinumtoxinA for chronic migraineComparison and overview of currently available neurotoxinsTherapeutic effect of Botulinum toxin-A in 88 patients with trigeminal neuralgia with 14-month follow-up.Blockade of glutamate release by botulinum neurotoxin type A in humans: a dermal microdialysis study.Therapeutic use of botulinum toxin in migraine: mechanisms of action.Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review.Development of an experimental model to study trigeminal nerve-mediated vasodilation on the human forehead.Effects of intraplantar botulinum toxin-B on carrageenan-induced changes in nociception and spinal phosphorylation of GluA1 and AktTime course analysis of the effects of botulinum neurotoxin type A on pain and vasomotor responses evoked by glutamate injection into human temporalis muscles.CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine.Botulinum Toxin in Migraine Treatment.Targeted treatment of pruritus: a look into the futureGuidelines and recommendations for assessment of somatosensory function in oro-facial pain conditions--a taskforce report.Optimizing the early phase development of new analgesics by human pain biomarkers.Botulinum toxin treatment of myofascial pain: a critical review of the literature.Refractory trigeminal neuralgia. Non-surgical treatment options.A new treatment paradigm for trigeminal neuralgia using Botulinum toxin type A.Translational pain biomarkers in the early development of new neurotherapeutics for pain management.Neurotrophins, endocannabinoids and thermo-transient receptor potential: a threesome in pain signalling.Emerging therapies for chronic migraine.Chronic migraine - new treatment options.Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behaviorRationale for use of onabotulinum toxin A (BOTOX) in chronic migraine.Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic Therapies.Abobotulinum Toxin A in the Treatment of Chronic Low Back PainTRPV1 receptor in the human trigeminal ganglion and spinal nucleus: immunohistochemical localization and comparison with the neuropeptides CGRP and SP.Cleavage of SNAP-25 ameliorates cancer pain in a mouse model of melanoma.Nonparalytic botulinum molecules for the control of pain.Modulation of inflammatory mediators in the trigeminal ganglion by botulinum neurotoxin type A: an organ culture studyBotulinum toxin type A reduces hyperalgesia and TRPV1 expression in rats with neuropathic pain.Botulinum Toxin in the Field of Dermatology: Novel Indications.Botulinum Toxin Type A Injection for Neuropathic Pain in a Patient With a Brain Tumor: A Case Report.Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.OnabotulinumtoxinA: preventive treatment for chronic migraine.
P2860
Q24201982-401E9029-E424-4414-BA95-9DBBA324E7DAQ24234904-A014877B-6C2E-4AFC-AA52-38705D28F8B1Q26778129-2C148044-E2BE-4FE3-8C37-A1423A14DE8DQ26781281-0E77D3B9-D948-4010-A886-F6AECDA939D9Q26859917-E95F2217-E4AB-4D82-9029-4B8471D3F40AQ27026720-01E55E1C-8CE1-49A5-A318-3DC64387AA45Q27027006-D0882E93-DF85-4E56-8DCC-F3182817C152Q27030752-55C8AB10-462C-4499-8838-5631B4C71992Q33828749-88EC5513-9CAB-4120-B24D-E4D13F9D4B55Q34154494-E3E8C083-0488-4433-A201-F4D1C007DF7CQ34419654-56418FA4-6A85-419E-96F5-51C3A80A16CAQ34960591-BA014295-E175-490A-9248-2731FC3B5227Q35082079-BBFEE08D-487A-4651-8462-38FA10A98F37Q37062762-C37C2B73-FEFE-43E0-8531-E99F220EF799Q37617800-891B5B0D-FE1E-4E2C-B2FE-0251822C0CD5Q37630537-140734A3-DD08-45B7-AA4B-27064FEC6ECBQ37703847-5FB59CF6-72EF-494D-A72E-70EEB64863B1Q37827172-44C44B9B-BD52-47FF-8A93-D852CD006050Q37829467-67C4F64F-BD1D-448A-8E61-0014D18E058AQ37947690-3FF61E46-75C6-4F21-B4C5-AC56F68F7B8DQ38025031-402A7C2B-88DB-49C7-9493-D697B3F13D6FQ38066141-7F38D93C-74A7-4274-8DA8-8A2D56FD6903Q38118652-E98EEEA3-DA75-46CE-9250-4101BE055E3BQ38184634-63BCE4D7-4422-45D0-A027-6152B5D4CB21Q38185067-14CDED93-99B1-476B-BFF1-D4D67A7ECCECQ38187606-53D857D6-E71F-4CD8-A9B3-F6C5F63879C4Q38364187-E5AF57F7-44C0-4F98-958C-CBC90B8BD165Q38365855-B492DF06-6B1D-4AC8-92B4-283192ADECCDQ38504707-CDEC4E29-5820-4D45-BB0A-417F80247123Q39026796-45F038A9-361E-4515-9335-D0043921ADE7Q39095007-8682C368-742F-44CA-9AC6-F3DEDE0BD81DQ39561157-C88BE360-BB75-4916-8B34-0A531761C8F8Q39683861-D7D8DC5B-97D9-4C5F-BFE3-A33A273FC371Q40113769-FB3E6AE4-66D0-4FA6-AE7E-D702270F6666Q42203910-B9B33F92-5D5C-486E-A4BF-2816BEF26E5AQ45731235-F7E2F72E-2145-41CF-AEC8-1784D731A7D9Q47095114-CD8E8477-5418-4994-8C79-A910AEB055E7Q47848932-83E3F722-2A0D-4ED2-905D-69C936779CF2Q48306948-027ABF82-CF56-4E16-AD02-3DBAFE48FA51Q49022075-6CE8A38D-294A-46BF-AD72-628C53D2EB47
P2860
Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Subcutaneous Botulinum toxin t ...... motor reactions in human skin.
@ast
Subcutaneous Botulinum toxin t ...... motor reactions in human skin.
@en
type
label
Subcutaneous Botulinum toxin t ...... motor reactions in human skin.
@ast
Subcutaneous Botulinum toxin t ...... motor reactions in human skin.
@en
prefLabel
Subcutaneous Botulinum toxin t ...... motor reactions in human skin.
@ast
Subcutaneous Botulinum toxin t ...... motor reactions in human skin.
@en
P50
P1433
P1476
Subcutaneous Botulinum toxin t ...... motor reactions in human skin.
@en
P2093
Camilla Staahl
Natalia Spicina Pedersen
P356
10.1016/J.PAIN.2008.10.005
P407
P577
2008-11-11T00:00:00Z